Position in ABBV
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$18,039,819
+$2,463,403 QoQ
Shares Held
71,689
+0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#659
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2021CallValue
$32,361
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. ABBV ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in ABBV
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,039,819 | 71,689 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $15,576,416 | 71,619 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,412,436 | 71,830 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $16,427,068 | 70,947 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,016,231 | 70,123 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $14,391,719 | 68,689 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $12,190,575 | 68,602 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $14,633,464 | 74,101 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,320,109 | 71,829 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,407,472 | 62,644 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $15,890,313 | 102,538 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $15,597,489 | 104,639 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $10,316,006 | 76,568 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $12,993,436 | 81,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,296,182 | 88,461 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,648,487 | 94,244 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $14,845,186 | 96,926 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $13,297,559 | 82,028 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $10,630,389 | 78,511 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $8,339,429 | 77,310 | Shares | Sole | 2021-12-03 | |
| 2021-09-30 | $32,361 | 300 | Call | Sole | 2021-12-03 | |
| 2021-06-30 | $7,565,465 | 67,165 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,000 | 400 | Put | Sole | 2021-05-24 | |
| 2021-03-31 | $5,325,830 | 49,213 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $4,666,703 | 43,553 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,390,608 | 38,710 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $3,175,828 | 32,347 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,102,005 | 27,589 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||